Onset of Action for Journavyx (Suzetrigine)
Journavyx begins providing perceptible pain relief within 60 minutes, with meaningful pain relief typically occurring around 2-4 hours after the initial loading dose.
Timeline for Pain Relief
Based on FDA-approved clinical trial data, the onset of Journavyx follows this pattern 1:
- Perceptible pain relief (≥1-point reduction on pain scale): 60 minutes median time
- Meaningful pain relief (≥2-point reduction on pain scale): 240 minutes (4 hours) median time in bunionectomy patients; 119 minutes (approximately 2 hours) in abdominoplasty patients
Critical Dosing Consideration
The first dose MUST be taken on an empty stomach (at least 1 hour before or 2 hours after food) to avoid delayed onset of action 1. This is essential for achieving the expected timeframe. Subsequent doses can be taken with or without food.
Context with Current Medications
Your patient is already taking gabapentin, hydrocodone, and carisoprodol. Important considerations:
- No significant drug interactions exist between Journavyx and these medications based on available data
- Journavyx works through a completely different mechanism (selective NaV1.8 sodium channel inhibition) than any of these drugs 2
- The patient should experience pain relief within the 1-4 hour window regardless of concurrent medications
Dosing Regimen
- Loading dose: 100 mg on empty stomach
- Maintenance: 50 mg every 12 hours thereafter 1
- Duration: Up to 14 days for acute pain
What to Expect
In clinical trials, 83-91% of patients rated Journavyx as providing "good to excellent" analgesia 3, 4. If adequate pain relief is not achieved within 2-4 hours after the loading dose, supplemental analgesia (including opioids like the patient's existing hydrocodone) should be considered 3.
Common Pitfall to Avoid
Do not take the first dose with food or grapefruit-containing products - this will significantly delay onset of action 1. Clear liquids (water, apple juice, vegetable broth, tea, black coffee) are permitted during the fasting period.